New patent for Ibsa Inst drug LICART

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for LICART
Annual Drug Patent Expirations for LICART

Licart is a drug marketed by Ibsa Inst Bio and is included in one NDA.

The generic ingredient in LICART is diclofenac epolamine. Additional details are available on the diclofenac epolamine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top